| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |